INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Columbia University
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Columbia University (39)
2024
-
p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway
Cell Reports Medicine, Vol. 5, Núm. 2
2023
-
Author Correction: γ-Linolenic acid in maternal milk drives cardiac metabolic maturation (Nature, (2023), 618, 7964, (365-373), 10.1038/s41586-023-06068-7)
Nature
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
-
γ-Linolenic acid in maternal milk drives cardiac metabolic maturation
Nature, Vol. 618, Núm. 7964, pp. 365-373
2022
-
Guiding the global evolution of cytogenetic testing for hematologic malignancies
Blood, Vol. 139, Núm. 15, pp. 2273-2284
2021
-
Author Correction: c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis (Nature Metabolism, (2020), 2, 11, (1350-1367), 10.1038/s42255-020-00306-2)
Nature Metabolism
-
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
British Journal of Haematology, Vol. 194, Núm. 3, pp. 496-507
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
-
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e119-e130
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
The Lancet Oncology, Vol. 22, Núm. 3, pp. e105-e118
2020
-
Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk
Journal of Hematology and Oncology, Vol. 13, Núm. 1
-
c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis
Nature Metabolism, Vol. 2, Núm. 11, pp. 1350-1367
2019
-
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
The Lancet Oncology, Vol. 20, Núm. 6, pp. e302-e312
-
Randomized phase III study of alisertib or investigator’s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma ¨
Journal of Clinical Oncology
2018
-
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: Updated analysis of CASTOR
Haematologica, Vol. 103, Núm. 12, pp. 2079-2087
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd
Nature Communications, Vol. 7
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
Heterogeneity of psychosis risk within individuals at clinical high risk: A meta-analytical stratification
JAMA Psychiatry, Vol. 73, Núm. 2, pp. 113-120